BioSpace News Archive

Apollo Endosurgery, Inc., a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced that it intends to offer and sell shares of its common stock in an underwritten public offering.

Inogen, Inc. (NASDAQ: INGN), (“Inogen” or “the Company”), today announced that Stanislav Glezer, MD has been appointed to the role of Chief Technology Officer responsible for R&D and Engineering, Medical Affairs, and Regulatory Affairs.

Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) (the “Company”), announced today that pre-clinical data that support anti-tumor activity of UCARTMESO will be presented at the Society for Immunotherapy of Cancer’s 36th Annual Meeting (SITC 2021).

Preliminary third quarter 2021 total revenue was $9.7 million, including product sales of $8.9 million. Preliminary core non-COVID-19 product sales increased 4% Y-Y to approximately $7.8 million.

Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, today announced that it will report financial results for the third quarter of 2021 after the market close on Wednesday, November 3, 2021.

Relay Therapeutics, Inc., a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, announced the pricing of an underwritten public offering of 13,207,547 shares of its common stock at a public offering price of $26.50 per share.

Imbed Biosciences, Inc. (Imbed) announced today the results of a prospective clinical evaluation of its next-generation wound matrix, Microlyte® SURGICAL, in diabetic patients undergoing foot and ankle surgery who would ordinarily be at risk of a surgical site infection.

Centinel Spine®, LLC, a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, today announced it has won a 2021 Orthopedics This Week Spine Technology Award for its new Angled Endplate implants for the prodisc® L Lumbar Total Disc Replacement System.

Magnolia Medical Technologies, Inc., inventors of Steripath®, today announced it has been awarded a national GPO and Value-Based contract with Premier Inc.

i2O Therapeutics, a developer of novel peptide- and antibody-based oral biologic products based on a proprietary ionic liquid platform, today announced the appointment of Kurt C. Graves as Executive Chairman.